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Summary Murine and human melanoma cells differ relatively reliably from non-tumorigenic melanocytes in
certain biological properties. When cultured at low pH, melanocytes tend to be pigmented and melanoma cells
unpigmented. The growth of virtually all metastatic melanoma cells is inhibited by phorbol esters such as TPA
(12-0-tetradecanoyl phorbol-13-acetate), which stimulate melanocyte growth. Melanocytes fail to grow in
suspension culture or produce tumours when implanted in animals, while many melanoma lines can do both.
Here we studied which of these properties were dominant in hybrid cells formed by fusion of drug-resistant
murine B16-FIORR melanoma cells to melanocytes of the albino and brown lines, melan-c and melan-b. The
albino melanocytes are unpigmented but well-differentiated, the brown melanocytes produce pale brown
pigment and the melanoma cells are unpigmented under the conditions used. All hybrid colonies observed
produced black pigment, except some melan-b/melanoma hybrids when growing sparsely with TPA. Thus
pigmentation was generally dominant. 14/15 hybrid lines showed stimulation of proliferation by TPA, as do
melanocytes. Most hybrid lines showed no or reduced capacity for growth in suspension, though some grew
better in suspension when TPA was present. There was marked suppression of the tumorigenicity of the
parental melanoma cells in 4/8 hybrids examined, and tumorigenicity was reduced in the others, despite
considerable chromosome loss by the passage level tested. Thus most properties of the non-tumorigenic
pigment cells were dominant, as often observed for other cell lineages, and providing further evidence for gene
loss in the genesis of malignant melanoma.
The relation between age and incidence suggests that the
number of events required to generate malignant melanoma
in humans is smaller than that for other cancers (Cook et al.,
1969). The study of melanoma may therefore provide one of
the simpler approaches to the formidable problem of analys-
ing what genetic changes, or other somatically heritable
events, are required to produce cellular malignancy. These
heritable changes can be classed in principle as either dom-
inant - the activation or acquisition of an oncogene that
promotes malignancy, or recessive - the loss or repression of
a normal cellular gene that suppresses malignancy (Cooper,
1990). The latter would be called a tumour suppressor gene
or anti-oncogene. Changes of both kinds have been identified
in human and animal tumours (Cooper, 1990; Harris, 1990;
Huang et al., 1988; Nigro et al., 1989).
To obtain an initial broad picture of whether dominant or
recessive changes or both are important in melanoma, we
have adopted the classical approach of somatic-cell hy-
bridisation (Harris et al., 1969; Fougere et al., 1972; Wiener
et al., 1972; Stanbridge & Ceredig, 1981). Previous workers
have reported the suppression of malignancy in hybrids
between melanoma cells and diploid fibroblasts or lym-
phocytes (Jonasson et al., 1977; Evans et al., 1982), but we
were interested to know whether this suppression would also
occur with nontumorigenic cells of the homologous lineage,
melanocytes. Another study concluded that the ability of
normal cells to reduce malignancy of cancer cells by fusion
depended on their somatic origin (Cowell & Franks, 1984).
We were also interested to know the dominance-recessiveness
relationships of specific biological properties which are rela-
tively reliable as markers of malignancy in the pigment-cell
lineage (Eisinger & Marko, 1982; Albino et al., 1986; Bennett
et al., 1987, 1989; Dotto et al., 1989; Herlyn et al., 1990),
with a view to further studies of the genes involved. These
markers are as follows. Firstly nontumorigenic human or
mouse melanocytes are generally well-pigmented (differen-
tiated) in culture whereas malignant melanoma cells are
either unpigmented or show light or variable pigmentation.
Secondly normal diploid melanocytes will not grow in stan-
dard culture medium with serum, and immortal nontumor-
igenic melanocytes show little or no growth in such media,
but both will grow well in the presence of the tumour pro-
moter 12-0-tetradecanoyl phorbol-13-acetate (TPA); however
the growth of metastatic melanoma cells in such a medium is
inhibited by TPA. Thirdly, as with other cell types from solid
tissues, nontumorigenic melanocytes will not grow in suspen-
sion in a semisolid medium whereas malignant melanoma
lines usually will. Lastly many malignant melanoma lines will
form tumours in nude mice or (where applicable) syngeneic
animals, whereas nontumorigenic cells by definition will not.
It has recently become possible to derive immortal lines of
nontumorigenic melanocytes from mice (Sato et al., 1985;
Bennett et al., 1987, 1989; Tamura et al., 1987). We have
now been able to fuse immortal melanocytes to melanoma
cells in culture, and to study the above properties on the
resulting hybrid cells. The present results were obtained using
murine melanoma cells. The three lines of immortal non-
tumorigenic melanocytes were the genetically albino (c/c) line
melan-c, the brown (b/b) line melan-b (Bennett et al., 1989),
and a doubly drug-resistant subline of the latter, described
below. The albino cells are unpigmented but well-differ-
entiated in culture, containing many unpigmented premel-
anosomes like mature albino melanocytes in vivo (ibid.). The
brown melanocytes form pale brown melanin pigment rather
than the black produced by wild-type cells. These genetic
markers are useful in distinguishing hybrid from parental
cells. The melanoma lines were a highly metastatic line from
black mice, B16-FIO (Fidler, 1975), and a doubly drug-
resistant subline of this, B16-FI0RR (Hart, 1984). Our results
broadly agree with the findings obtained by those who hybri-
dised normal and malignant cells from disparate lineages,
namely that most of the properties of the normal cells were
dominant (displayed by most or all hybrid cells), although
some exceptions were observed. This encourages a search for
tumour suppressor genes expressed by melanocytes and not
by melanomas.
Matenrals and methods
Materials
TPA, mercaptoethanol, soybean trypsin inhibitor, ouabain
and other drugs were obtained from Sigma Chemical Co.
(Poole, Dorset, UK). Agarose (Seaplaque) was from ICN
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Biomedicals (High Wycombe, Bucks., UK). Sources of other
materials have been described previously (Bennett et al.,
1986, 1989).
Cell culture conditions
Melanocyte and melanoma cell lines were cultured as prev-
iously described (ibid.), in Eagle's minimum essential medium
(MEM) buffered to pH 6.9 (25 mM sodium bicarbonate for
10% C02), supplemented with sodium pyruvate, penicillin,
streptomycin, nonessential amino acids (supplemented MEM
or SMEM) and with 5% v/v foetal calf serum (FCS). For
melanocytes, 2-mercaptoethanol (2-ME) (100 ltM) and TPA
(200 nM) were added. Hybrid cells were grown with 2-ME
and with or without TPA (200 nM) as specified. The medium
was changed every 3-4 days and cultures were passaged
while still growing. They were replated at 2 x 104 ml- '. When
any culture became very sparse, generally during drug treat-
ments, Ham's F1O medium with 18 mM bicarbonate (pH 6.9)
was substituted for SMEM.
Cell lines
B16-FIO and B16-FI0RR cells were kindly provided by Dr
Ian Hart, Imperial Cancer Research Fund, London WC2.
The B16-Fl0RR line is resistant to ouabain and 6-thio-
guanine and was maintained in the presence of both drugs
(6 mM and 15 ILg ml-' respectively).
A line resistant to hygromycin B was derived from the
primary uncloned brown melanocyte line from which the
melan-b clone was also obtained, as follows. Melanocytes
were plated at 6 x 104 cells ml-', 10 ml/90 mm dish. One day
later they were exposed to a calcium phosphate coprecipitate
containing 1 iLg/dish of DNA of the plasmid pUC-Y3 (R.
Allshire, unpublished). This is derived from pY3 and, like
pY3, contains the hygromycin B phosphotransferase gene
under the control of the long terminal repeat regulatory
sequence of Moloney sarcoma virus (Blochlinger & Diggel-
mann, 1984). The transfection medium was as Dulbecco's
modification of Eagle's medium (pH 7.4) with TPA and 5%
FCS. After a day the cells were washed and returned to
melanocyte medium. They were selected in hygromycin B from
day 3, generally at 200IM although the concentration was
reduced for very sparse cultures. A small number of resistant
colonies were obtained, and some were subcultured after 6
weeks, with cloning rings, to produce cell lines. One clone was
selected for further work and designated 'melan-bH .
Trypsinised suspensions of melan-bH cells (1.5 x I07 in all)
were mutagenised with 300-600 rad of gamma radiation,
replated and cultured until cell death ceased, then exposed to
6-thioguanine (30 Lg ml-') as well as hygromycin B (200 JM).
Hygromycin was omitted when cultures became very sparse.
A single healthy colony was obtained and was subcultured
after 7 weeks to give a cell line resistant to both drugs,
melan-bHT. Tests confirmed sensitivity to HAT medium, i.e.
the HGPRT- phenotype.
Cellfusion procedure
A number ofpigment cell lines are sensitive to toxic effects of
polyethylene glycol (PEG). After developing a successful
fusion procedure for them using PEG, we were surprised to
observe a higher efficiency of hybrid cell production with the
same procedure when PEG was omitted. This procedure, its
requirements and range of applicability will be discussed
elsewhere (W.F.W., J.G. & D.C.B., manuscript in prepara-
tion).
Growing cultures were harvested as usual, except that
incubation with trypsin was continued for double the time
required when passaging: approximately 6 and 8 min respec-
tively at 37°C for the B16-F1O and melanocyte lines. Cells
were resuspended in Dulbecco's phosphate-buffered saline
with no calcium or magnesium (PBSA), containing an
amount of soybean trypsin inhibitor (TI) equivalent to the
trypsin present, as specified by the supplier (Sigma). The cells
were diluted to 2 x I05 ml-' in serum-free, bicarbonate-free
SMEM, adjusted with sodium hydroxide after equilibration
with air to give approximately pH 7.2-7.4. Equal volumes of
the two cell suspensions were mixed and centrifuged at 200g
for 10 min at room temperature. The cell pellets were drained
well and resuspended at 105mlh' in SMEM containing 5%
FCS and 2-ME. Ten ml of cell suspension were added to
each of eight 90 mm tissue culture dishes. Control cultures of
each of the parental lines were prepared in the same way but
plated at 5 x 104 ml1'.
Selection regimes were started 24 h after plating. For B16-
FlORR/melanocyte fusions, HAT (hypoxanthine, aminopterin
and thymidine) (Littlefield, 1964) and 6 mM ouabain were
added. HAT medium is toxic to thioguanine-resistant cells,
both properties resulting from the absence of functional
HGPRT enzyme (hypoxanthine-guanine phosphoribosyltrans-
ferase). To the melan-bHT/melan-c fusions HAT medium and
200ItM hygromycin B were added initially, but the level of
hygromycin was increased to 300tLM at day 4 and 400fLM at
day 8, to overcome the continued proliferation of melan-c
cells in the presence of this antibiotic. For all fusions, TPA
(200 nM) was added to four dishes at 24 h.
Assessment ofhybrid colony numbers, sizes andpigmentation
Two cultures with TPA and two without were fixed at day 14
for the B16-FIORR/melanocyte fusions, and at day 21 for the
melan-bHT/melan-c fusions. Cultures were washed once with
PBSA, fixed in 5 ml of 4% formaldehyde in PBSA for 5 min,
rinsed in 70% ethanol and air-dried. Hybrid colonies were
usually pigmented and were easily counted using a binocular
dissecting microscope (Nikon) with zoom objective, fibre-
optic epi-illumination and a white stage with a counting grid.
Total magnification was x 20. All colonies were counted.
The number of cells in each colony was counted or, for
larger colonies, estimated as the square of the number ofcells
in a diameter. Colonies were also scored as pigmented or
unpigmented. Partially-pigmented colonies (see Results) were
classed as pigmented. Plates observed by microscope to con-
tain any unpigmented cells were lightly stained with Giemsa
to facilitate counting without obscuring pigment.
Subculture ofhybrid clones
Selected colonies of hybrid cells, assumed to be clones, were
subcultured using plastic cloning rings when larger than 400
cells, and replated in 15 mm tissue culture wells with 1 ml of
growth medium containing trypsin inhibitor. Hygromycin B
and ouabain selections were discontinued at this stage, and
HAT was replaced by HT (hypoxanthine and thymidine)
only (Littlefield, 1964) for another 7 days. When nearly
confluent the hybrid lines were passaged again to 50mm
dishes (passage 2).
Estimation ofpopulation doubling times
Hybrid cell lines at passage 3, or parental lines at passage
levels near those used for fusion, were plated on four 90 mm
dishes at 2 x 104 ml-', 10 ml/dish. TPA (200 nM) was added
to two dishes. Cells were harvested after incubation for 96 h,
and pooled from both dishes. The cell number was estimated
by quadruplicate haemocytometer counts; an arithmetic
mean was taken, and crude doubling times were calculated
from this and the plating density.
Clonalgrowth in suspension
This assay was a modification of the two-phase agar system
(e.g. Freedman & Shin, 1974). The culture medium was
Ham's FIO with 18 mM bicarbonate (pH 6.9), 5% FCS and
100 tLM 2-ME, throughout. Four ml of medium containing
0.6% Seaplaque agarose were allowed to set in each 50 mm
tissue culture dish. This was overlaid with 2 ml of medium
containing 0.3% agarose and 200 hybrid cells at passage 3,
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treatment. Two ml of medium were added on day 7 and
renewed on day 14. TPA (200 nM) was included in the
agarose mixtures and liquid medium where specified. After 21
days, colonies were counted and their diameters were deter-
mined, with an inverted microscope (Olympus) equipped with
a calibrated eyepiece graticule.
Tumorigenicity tests
Cell lines were implanted into BALB/c thymus-deficient (nul
nu) mice and C57BL/6 mice (syngeneic with B16 cells). Each
of four or five mice per line received 106 hybrid cells or
5 x 104 melanoma cells in 0.2 ml PBSA, subcutaneously in
the flank region, and was assessed for palpable tumour
growth twice weekly for 11 or 12 weeks, except that mice
with tumours larger than 1 cm were killed for autopsy.
Karyotypic analysis
Hybrid cells at passage 3, melan-c and melan-b at higher
passage levels than used for fusion, and the B16-FI0RR line
were examined for marker chromosomes by standard trypsin-
Giemsa banding, essentially as described elsewhere (Muschel
et al., 1986). The means and ranges of chromosome numbers
were estimated from approximately 20 spreads per line.
Results
Pigmentation
None of the parental lines used here have black pigment
under the culture conditions described, for genetic reasons in
the case of the albino and brown melanocytes (see Introduc-
tion). B16-FIO melanoma cells are from C57BL black mice,
but when kept below confluence and at low pH as described
(Materials and methods) they are unpigmented (Bennett et
al., 1986), as are B16-F10RR cells. However black pigment
was observed in hybrid cells in all the following cases. Hyb-
rid cells or colonies were taken to be those surviving after all
cells in separate cultures of the parental lines had been killed
by the drug selections. Counts were performed when discrete,
sizeable colonies were visible: day 14 or 21 as specified.
After fusion of melan-c albino melanocytes to B16-Fl0RR
cells, small pigmented colonies and single cells were first
observed after 7 days (in dishes containing TPA). One hun-
dred per cent of hybrid cells and colonies at day 14 had
black pigment (Figure 1), of several thousand observed after
growth either with or without TPA. These included many
large single cells and groups of two or three cells. Some such
pigmented cells appeared moribund and/or subsequently died
in the cultures that were not fixed.
After fusion of melan-b and B16-Fl0RR cells, many black-
pigmented single cells and small colonies were first observed
at day 5, in cultures grown without TPA. In these cultures,
again no unpigmented cells or colonies were observed at day
14. However both pigmented and unpigmented hybrid clones
were obtained by growth in the presence of TPA, as detailed
below. In a related experiment, melan-bHT cells were fused
with B16-FIO (non-resistant) cells. Numerous black-pig-
mented colonies were obtained in cultures containing TPA
and apparently fewer without TPA; however it was not
possible to analyse this experiment in detail because the
concentration of hygromycin B required to kill the melanoma
cells appeared too detrimental to the hybrids.
All hybrid cells and colonies obtained 21 days after fusion
of melan-c with melan-bHT melanocytes had black pigment.
These were first observed as groups of 4-5 cells on day 8, in
cultures that contained TPA. With these hybrids, all cells in
cultures lacking TPA were dead by day 12.
Effects of TPA on hybrid colony growth
All fused cultures were grown both with and without TPA
from an early stage (24 h after fusion), in case some hybrid
cells were unable to proliferate in one or other condition.
This also enabled an overall assessment of responses to TPA
by large numbers of hybrid clones. Frequency distributions
of hybrid colony sizes after growth with and without TPA
are shown in Figure 2.
For melan-c/B16-F10RR hybrids, 58% more clones of four
cells or more were obtained with TPA than without, and
there was a clear shift in the frequency distribution to col-
onies of larger sizes. Thus over a third of hybrid clones were
unable to grow in the absence of TPA, and there was a
general tendency to more rapid growth in its presence. For
melan-b/B16-F10RR hybrids there was no significant
difference in the total numbers of clones obtained but there
were fewer small and more large colonies after growth with
TPA, the difference being highly significant by the chi-
squared test (P<.001). Thus, in general, hybrid cells from
this combination could grow in the absence of TPA, but a
proportion did grow better in its presence. For melanocyte/
melanocyte hybrids, as mentioned above, surviving cells and
clones were obtained only in the presence of TPA. After TPA
was omitted from the medium of some such hybrid clones
following subculture, they ceased to grow.
Some hybrid colonies (assumed to be clones) were subcul-
tured (Methods) from plates which either had or had not
been supplemented with TPA. Interestingly several melan-c/
B16-FI0RR clones growing without TPA, which were marked
prior to subculture, ceased to grow at the 200-400 cell stage.
One similar clone stopped growing after subculture and the
cells started to die; this clone was recovered by addition of
200 nM TPA, apparently from one viable cell.
Effects of TPA on pigmentation ofhybrids
Melan-b/B16-F10RR hybrid colonies and single cells obtained
without TPA were all black-pigmented (Figure 3a), but those
obtained in the presence of TPA included many unpigmented
colonies as well as pigmented ones (Figure 2c). However at a
later stage, such unpigmented colonies frequently showed
pigmentation at the colony centre, which became more exten-
sive over 2-3 days as the colonies enlarged. Thus the propor-
tion of completely unpigmented colonies at 14 days (68% of
the total in Figure 2c) was probably an arbitrary figure
reflecting the colony size distribution. After subculture of
unpigmented hybrid clones, onset of pigmentation was ob-
served as they neared confluence, indicating that the pigmen-
tation appeared at higher local cell densities (as found in
Figure 1 Macroscopic appearance of hybrid and parental cells in
90 mm dishes. Melan-c and BI6-F10RR cells were fused as in
Materials and methods. a,b, Confluent cultures of parental cell
lines melan-c and B16-F10RR respectively showing lack of pig-
ment. c,d, Fused cultures growing in the presence and absence of
TPA respectively, showing marked pigmentation and relative
numbers of hybrid colonies. Many small colonies are not visible.532 W.F. WAKELING et al.
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Figure 2 Size distributions of initial hybrid colonies obtained in media with and without TPA. Colonies were counted and their
sizes (number of cells) and pigmentation noted as described (Materials and methods). Colonies of less than four cells were
excluded. The cell number on the right of each column was included in that column. Total colony number refers to the mean of
numbers on both 90 mm dishes. a,b, melan-c/B16-Fl0RR hybrids grown with and without TPA respectively and assessed at day 14.
No unpigmented colonies were observed. The total numbers of colonies were 306 in the presence and 176 in the absence of TPA.
This contrasts with the total numbers of groups of two and three and single pigmented cells which were 814 in the presence and
593 in the absence of TPA. c,d, melan-b/B16-FIORR hybrids grown with and without TPA respectively and assessed at day 14.
Pigmented and unpigmented colonies are shown by shaded and unshaded areas respectively. Total numbers ofcolonies were 465 in
the presence and 498 in the absence ofTPA. A total of 273 groups of two and three and single pigmented cells were noted in those
dishes which had no TPA added. e, melan-c/melan-bHT hybrids grown in the presence of TPA and assessed at day 21. 35 colonies
were obtained. No unpigmented colonies were observed, and no colonies at all in the absence of TPA.
centres of larger colonies). B16 melanoma cells similarly
become pigmented at high densities, even at the low pH used
here (Laskin et al., 1980). When the TPA supplement was
omitted from subcultures ofunpigmented melan-b/B16-FlO1RR
hybrid colonies, plated at low cell density (2 x 104mlh'),
local pigmentation was observed within 5 days (Figure 3b)
and all cells pigmented over a longer period.
General observations on hybrid clones subcultured as cell lines
Selected colonies were subcultured from day 21 onwards
(Methods), for further characterisation. They were selected
initially for differences in colony size, pigmentation and mor-
phology, and from cultures originally grown with and with-
out TPA. Cell morphology of most hybrids proved however
to vary with cell density and perhaps passage number, and
could not therefore be used reliably to classify hybrid cell
lines. Pigmentation also varied with cell density in melan-b/
B16-FlORR hybrids as just described.
It should be stressed that the 19 hybrid lines studied
cannot necessarily be taken as a completely representative
sample of the thousands of original hybrids, especially given
that many of the latter failed to grow progressively at all
(Figure 2).
Proliferation rates ofhybrid lines and effects of TPA
Lines from hybrid colonies selected initially in the presence
or the absence of TPA were each passaged into media both
with and without TPA. Estimates of crude doubling times
over 4 days showed that all hybrids grew more slowly than
the melanoma cells under both conditions, while most mel-
anoma/melanocyte hybrids grew faster than the parental
melanocyte lines (Table I). All tested hybrid clones showed a
stimulation of growth by TPA, except one; this one (F7.1 1B)
was a melan-b/B16-FIO hybrid initially obtained without
TPA (Table I).
The melanocyte/melanocyte hybrids had doubling times
comparable with those of the parental lines in the presence of
TPA. When TPA was excluded from the culture medium
their rate of proliferation slowed markedly over 4 days
(Table I), and they adopted a more epithelioid morphology,
also characteristic of melanocyte lines (Bennett et al., 1987,
1989).
The effects of TPA on the Bl6-FlORR parental line were
also examined, as this had not been done previously. Pro-
liferation of these cells over the first 4 days in the presence of
TPA was slightly inhibited, their doubling time being 0.92
days compared with 0.85 days in its absence. However other
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Table I Effect ofTPA on adherent growth ofhybrid and parental cell
lines
Doubling time of
adherent cultures
(days)a
Cell line + TPA - TPA
Parental cell lines:
B16-F10RR 0.92 0.85
melan-c 2.98 5.45
melan-b 2.46 b
melan-c/B16-FI0RR hybridsc:
F5.3A 1.34 2.19
F5.6A 1.65 2.74
F5.7A 1.39 3.88
F5.22A 1.31 1.6
FS.lB 2.57 3.52
F5.4B 1.91 3.55
F5.5B 1.26 1.55
F5.8B 2.06 2.78
melan-b/B16-F10RR hybrids:
F7.14A 1.55 1.93
F7.19A 2.38 3.98
F7.21A 1.8 2.32
F7.4B 1.52 1.84
F7.5B 1.28 1.66
F7.8B 1.54 1.97
F7.11B 1.47 1.18
melan-c/melan-bHT hybrids:
F9.1A 3.38 5.66
F9.2A 2.49 6.29
F9.3A 3.01 cod
F9.SA 2.37 7
aCrude doubling times over 4 days on plastic were measured as in
Materials and methods. bNot done. Melan-b cells grew poorly in the
absence ofTPA (Bennett etal., 1989).cHybrid linesdesignated A and B
were selected originally in the presence and absence of TPA,
respectively. dNo significant change in cell number.
Figure 3 Melan-b/B16-FI0RR hybrids. The cells were cultured as
in Materials and methods and photographed through an Olym-
pus inverted microscope. a, Pigmented clone selected in the
absence of TPA. Bright field illumination; scale bar 200 lm. b,
F7.19A hybrid, unpigmented when initially selected in the pre-
sence of TPA, showing reversion to pigmentation at low cell
density after culture for 5 days in the absence of TPA. Phase
contrast illumination; scale bar 200 lsm.
work with B16-F10 cells (non-drug-resistant) showed that
after two subcultures (7 days) in the presence of TPA, their
growth rate with TPA over the next 4 days was markedly
lower, typical doubling times being 1.0-1.1 days, compared
with 0.65-0.7 days without TPA for this line (increases of
around 15-fold instead of 60-fold over 4 days).
Clonogenicity ofhybrid lines in semisolid agarose, and effects
of TPA
The percentages of cells forming colonies in suspension in
two-phase agarose, for parental and hybrid lines, are shown
in Table IT. The two melanocyte lines and all hybrids
between them formed no colonies in suspension, with or
without TPA, while the clonogenicity of the parental melan-
oma cells was high (52%) in the absence of TPA, or lower
(6%) in its presence. The melanocyte/melanoma hybrid lines
varied in their capacity to grow in suspension. Among melan-
b/B16 hybrids, most (4/7) formed no colonies, two had clon-
ing efficiencies below 1% with or without TPA and the
remaining line had clonogenicities of 0 in the absence of TPA
and 1.5% in its presence. Thus the ability of melan-b/B16
hybrids to grow in suspension was zero or markedly lower
than that of the melanoma cells; where not zero it may have
been stimulated slightly by TPA. Of eight melan-c/B16 hyb-
Table II Effect ofTPA on non-adherent clonogenic growth ofhybrid
and parental cell lines
Cloning efficiency
in suspension (%)a.b
Cell line + TPA - TPA
Parental cell lines:
Bl16-FI0RR 5.7 (0.12) 52 (0.3)
melan-c 0 0
melan-b 0 0
melan-c/B16-F10RR hybrids:
F5.3A 48 (0.06) 0.75 (0.05)
F5.6A 1 (0.05) 0
F5.7A 2.5 (0.05) 0
F5.22A 37 (0.09) 0
F5.lB 17 (0.1) 14 (0.06)
F5.4B 0.83 (0.05) 0.33 (0.05)
F5.SB 3.83 (0.05) 0
F5.8B 22 (0.11) 10 (0.08)
melan-b/B16-FIORR hybrids:
F7.14A 1.5 (0.05) 0
F7.19A 0 0
F7.21A 0 0
F7.4B 0.83 (0.11) 0.33 (0.1)
F7.5B 0.83 (0.05) 0.33 (0.05)
F7.8B 0 0
F7.11B 0 0
melan-c/melan-bHT hybrids:
F9.IA 0 0
F9.2A 0 0
F9.3A 0 0
F9.5A 0 0
aCloning efficiencies over 21 days in soft agarose were measured as in
Materials and methods. bFigures in brackets represent the mean colony
diameter (mm). Differences in colony sizes between hybrids grown with
and without TPA were not significant by thechi-squared test (P<0.1).
a
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rid lines tested, most showed different behaviour with and
without TPA. In the absence of TPA, four lines were unable
to form suspension colonies, two showed less than 1%
clonogenicity and the other two formed significant numbers
of colonies (14%, 10%). However when TPA was present, all
hybrids formed some colonies. Four had cloning efficiencies
of 3% or less, while those of the other four were 17% or
more. Thus for this set of hybrids, the clonogenicity in
agarose tended to be intermediate between those of the
parental lines, although generally near zero in the absence of
TPA. Where hybrids formed colonies both with and without
TPA, most had marginally larger mean diameters in the
presence of TPA but this was not significant by the chi-
squared test (P>0.1).
Tumorigenicity ofhybrid lines
Hybrid lines were selected for tests of tumorigenicity in
animals on the basis of either high or low cloning efficiencies
in suspension. This was to test whether the two properties
were correlated, as reported for other cell types by some
authors (e.g. Freedman & Shin, 1974). Cells at passage 5
were implanted into nude and C57BL/6 mice, the latter
syngeneic with B16 cells. For comparison, the melan-b and
melan-c lines formed no tumours in 6 months after implanta-
tion of 2 x 106 cells in each of ten mice per line (Bennett et
al., 1989), while B16-FlORR cells were tumorigenic in 100%
of syngeneic mice within 4 weeks from an inoculum of
5 x 104 cells (Table III) or even within 2 weeks, from an
inoculum of 105 cells (I.R. Hart, personal communication).
A total of 4 melan-c/B16-F1IRR and 4 melan-b/Bl6-F1ORR
hybrids were examined for tumorigenicity (Table III). Four
hybrids, namely two melan-c/B16-F1ORR (F5.3A and F5.6A)
and two melan-b/B16RR hybrids (F7.21A and F7.5B) showed
a marked reduction in tumorigenicity. Latent periods were
generally long and some mice developed no tumour in the
test period. Although the remaining hybrids produced tu-
mours in both nude and C57BL/6 mice in 4-6 weeks, their
tumorigenicity was still distinctly lower than that of the
melanoma line, since not all mice had tumours at 4 weeks
from a relatively large inoculum. From the hybrid lines
examined, there appeared to be no difference in the ability of
melan-c and melan-b cells to suppress the tumorigenicity of
the melanoma. There was no evidence for a correlation
between tumorigenicity of the hybrids and their growth in
semisolid medium (note L and H designations, Table III),
although sample sizes were small.
Karyology
Modal chromosome numbers of 40 (diploid) for melan-c and
39 for melan-b cells were established previously from 50
spreads per line, from cultures at passage levels near those
used in the present experiments (Bennett et al., 1989). The
present banding studies failed to reveal marker chromosomes
in either melanocyte line. B16-F1ORR cells had a narrow
range of chromosome numbers (75-77, mode = 76) (near
tetraploid). Several marker chromosomes were found, includ-
ing a Robertsonian translocation between chromosomes 12, a
metacentric chromosome 10 with additional unidentified non-
centromeric DNA and other small unidentified metacentric
chromosomes.
Spreads were prepared from 10 melanocyte/melanoma hy-
brid lines at passage 3. These did not generally have distinct
modal chromosome numbers. Melan-c/B16 hybrids (F5 des-
ignations) generally had wider ranges than melan-b/B16 hy-
brids (F7 designations), but mean numbers of chromosomes
were similar. Actual means and ranges were:- F5.3A, 94.2
(64-104); F5.6A, 95.2 (57-116); F5.7A, 103.9 (92-136);
F5.22A [passage 5], 84.2 (63-98). F7.19A, 100.3 (98-104);
F7.21A, 95.2 (85-104); F7.4B, 95.3 (76-106); F7.5B, 95.3
(64-127); F7.8B, 93.3 (76-98); F7.11B, 101 (96-106).
These numbers and the presence and numbers of B16-
F1ORR marker chromosomes in each hybrid suggested that all
the hybrids examined had originally received a single nucleus
from each parental line. Chromosome loss was thus quite
extensive in all hybrids, even at the earliest possible stage for
study after fusion (passage 3).
Discussion
Pigmentation
The pigmentation of the melanocyte/melanoma hybrid clones
was most interesting. It appeared that all melan-c/B16 hybrid
cells were black-pigmented, so that the differentiated state of
the normal melanocytes was unequivocally dominant here.
The same can be said of melan-b/B16 hybrid cells cultured
without TPA. However the latter hybrids in the presence of
TPA behaved somewhat like B16 melanoma cells grown
without TPA: pigmentation was absent in sparse cultures but
appeared in locally dense areas. We have no explanation for
this difference between the two sets of hybrids. It presumably
reflects a difference between the melan-b and melan-c lines,
which probably arose during their establishment rather than
Table III Tumorigenicity of hybrid cell lines
Tumour incidencea
Cell line C57BL/6 mice BALB/c nu/nu mice Summar/
Time: 4 wk 6 wk 12 wk 4 wk 6 wk 1J wk
B16-Fl ORR 5/5 ND + + +
melan-c/B16-FIOR5 hybrids:
F5.3A (H)C 0/5 1/5 4/5 0/5 0/5 3/4 +
F5.6A (L) 0/2 0/2 0/2 0/3 0/1 1/1 -/+
F5.7A (L) 2/5 3/5 5/5 1/5 4/4 4/4 + +
F5.22A (H) 1/5 5/5 5/5 1/4 4/4 4/4 + +
melan-b/B16-F1ORR hybrids:
F7.19A (L) 4/4 4/4 4/4 2/3 2/3 2/3 + +
F7.21A (L) 0/4 1/4 1/4 0/4 0/4 3/4 +
F7.4B (L) 4/4 4/4 4/4 3/4 3/3 3/3 + +
F7.5B (L) 0/4 1/4 2/4 0/4 1/4 4/4 +
aNumber ofmice with tumours out oftotal surviving mice, assessed as described in
Materials and methods using 106 hybrid cells per mouse, or 5 x 104 B16-FIORR
melanoma cells. ND: not done; hybrid lines were tested in both C57BL/6 and nu/nu
mice in case they were rejected by the C57BL/6 mice, whereas B16-FlORR cells were
tested only in C57BL/6 mice with which they are syngeneic. bSummary of
tumorigenicity: (-): no tumours in 12 weeks; (+): low tumorigenicity - under 30%
mice with tumours in 6 weeks; (+ +): tumorigenic but < 100% in 4 weeks; (+ + +):
highly tumorigenic - 100% in 4 weeks (or in 2 weeks; see text), from a much smaller
inoculum. C(L) and (H) designate low and high clonogenicities in suspension,
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from the mouse strains of origin. The melan-c/melanoma
hybrids did appear less pigmented when growing with TPA
than without, but did not become unpigmented. Possibly
melan-b cells are in some sense less maturely differentiated
than melan-c cells, producing a corresponding difference in
their hybrids with B16-FIO cells. Human melanoma cells
have been classified into three sets with different levels of
differentiation (Houghton et al., 1987); however both melan-
b and melan-c cells would fall into the most-differentiated
class in this system, since they synthesise melanosomes and
melanosomal enzymes.
These results are comparable with other reports that when
non-tumorigenic cells with a differentiated function, such as
keratinocytes, are fused to malignant cells of another lineage,
the hybrids before extensive chromosome loss tend to adopt
the program of differentiation of the non-tumorigenic fusion
partner, this behaviour usually being associated with a lack
of tumorigenicity (Wiener et al., 1972; Stanbridge & Ceredig,
1981; Cowell & Franks, 1984; Harris, 1990), although not
always (Cowell & Franks, 1984). An early report of two
hybrid lines, formed by spontaneous fusion in vivo between
subtetraploid mouse melanoma cells and unknown diploid
host cell types(s), mentioned that both lines, while tumori-
genic, showed increased pigment synthesis in culture com-
pared to the melanoma cells (Halaban et al., 1980).
An incidental outcome of the pigmentation of our hybrid
cells was that we could identify them at a very early stage, as
groups of one or a few black cells. This permitted the addi-
tional observation that many hybrids, in fact the majority of
melan-c/B16 hybrids (Figure 2), failed to divide in 14 days,
or apparently stopped growing after very few divisions. This
may have been due to cell-cycle incompatibilities, loss of vital
chromosomes, drug effects, gene dosage effects or perhaps to
complementation between different mutations producing im-
mortality, resulting in senescence of hybrid cells, as reported
for hybrids between human cell lines (Pereira-Smith & Smith,
1988). In the last case, chromosome loss would be necessary
for any progressive hybrid cell proliferation. This observation
reinforces the view that the properties of the hybrid lines
analysed may not have been fully representative of the
original hybrid population; the lines may well have been less
'normal' than average. In most other such studies, of course,
the only hybrid cells detected have been those that grew
progressively.
Proliferation and effects of TPA
In the proliferation rates of the hybrid cells in standard
(adherent) cultures, the behaviour of neither the malignant
nor the non-malignant cells was completely dominant. All
hybrids that were examined as cell lines were able to grow in
the absence of TPA, like melanoma cells and unlike melan-
ocytes, but their growth rates without TPA were generally
markedly lower than those of the melanoma cells. Prolifera-
tion rates of hybrid lines in the presence of TPA were also
generally intermediate between those of the melanocytes and
the melanoma cells. One interpretation is that proliferation
rates are determined by more than one gene, and among
these genes, dominance of one or more melanocyte genes is
offset by dominance of one or more melanoma genes. On the
other hand, fewer growing colonies were originally obtained
in the absence than in the presence of TPA after fusion of
melan-c and B16 cells; this suggests that initially, at least,
some hybrid cells were present that could grow in the
presence but not the absence of TPA. It should be noted that
faster-growing subpopulations arising in a clone through loss
of melanocyte-derived chromosomes could soon come to
predominate numerically.
Perhaps more striking was the direction of the proliferative
response of each hybrid to TPA. All melan-c/B16 hybrids
and all but one melan-b/B16 hybrid tested grew faster with
TPA than without, like melanocytes and unlike melanoma
cells. This is thus another property of the non-tumorigenic
cells that behaves dominantly. The exceptional clone
(F7. 1 1B) had been obtained in the absence of TPA, so
selective pressure could have led to loss of relevant chrom-
osome(s) derived from the melanocyte parent line.
Growth in suspension
The high clonogenicity in agarose of the B16-FI0RR melan-
oma cells was suppressed completely in some hybrids with
melan-b, and in some hybrids with melan-c so long as TPA
was absent. Other hybrids grew in suspension to various
extents, though none grew in the absence of TPA so well as
the melanoma cells. The growth rates of different hybrid lines
on a substrate with and without TPA did not correlate well
with their growth in agarose, so the stimulation of hybrid cell
growth in suspension by TPA cannot be attributed in a
straightforward way to its ability to stimulate cell prolifera-
tion. In general the variability in growth in agarose within
and between the lines may be attributable to variable loss of
relevant chromosome(s). However suppression of melanoma
growth in agarose appeared more marked in hybrids with
melan-b than with melan-c cells, even though rates of
chromosome loss by passage 3 appeared to have been similar
in both sets in those hybrids karyotyped. This suggests in-
stead another pre-existing difference between the two melan-
ocyte lines.
Tumorigenicity
There is a consensus from previous studies that hybrids
between non-tumorigenic and tumorigenic cells (including
melanoma cells) tend to be non-tumorigenic before chromo-
some loss (e.g. Stanbridge & Ceredig, 1981; Harris, 1990).
Our results are consistent with this idea; the observation of
some mice free of tumours at the end of the assay period,
and the often long latent periods, indicate that in general the
tumours arose from a small minority of the implanted cells.
Tumorigenicity would be below 1 cell in 106 for lines not
tumorigenic in all mice. This represents almost complete
suppression as compared to B16-Fl0RR cells, of which at
least 1 in 50,000 is tumorigenic from Table III, and at least 1
in 500 in the tests of Hart (1984) (under different conditions).
Considerable chromosome loss had occurred by the passage
(number 5) at which enough cells were available for implan-
tation in mice, so that the tumours observed can be explained
by the loss of chromosome(s) necessary for suppression. The
observation that no tested hybrid was as tumorigenic as the
melanoma cells suggest that more than one gene from the
melanocytes was capable of reduction of tumour growth.
Incidentally a suppression of tumorigenicity is not caused
by hybridisation itself in these cells. Hart (1984) fused B16-
F1ORR cells to various other cell lines and observed a reduction
of malignancy only when the other line was non-tumorigenic.
Similar results were obtained by others; for example 16/16
hybrid lines from combinations of various other tumorigenic
murine lines were tumorigenic (Wiener et al., 1973), and
human tumour lines too remained tumorigenic when cross-
hybridised (Stanbridge et al., 1982).
None of the other cellular properties analysed (pigmenta-
tion at low pH, response to TPA and growth in agarose) was
a predictor of the tumorigenicity of these hybrid clones, but
this finding is compromised by the cellular heterogeneity
resulting from variable chromosome loss. The properties
measured in vitro are those of the majority cell population,
but the tumorigenicity depends on the most tumorigenic cells
present, often a small subpopulation as just mentioned, of
which the properties in vitro would not be known - e.g.
growth in suspension of 1 in 106 cells would not be detected.
Moreover, tumorigenicity tests were done two passages later
than the other tests, allowing further chromosome loss. Each
of the said properties is correlated with cellular malignancy
among pigment cell lines in general (see Introduction).
Implicationsfor melanoma genetics
In short, of the properties studied in these hybrid cells, most
seemed closer to those of the non-tumorigenic melanocytes536 W.F. WAKELING et al.
than those of the melanoma cells, and chromosome loss was
sufficient to account for most deviations from this rule, even
though the melanocytes used here were immortal rather than
fully normal. It is possible that a still higher degree of
'normalisation' would have been seen with newly explanted,
diploid murine melanocytes, which, however, are difficult to
work with because of their rapid senescence and overgrowth
by immortal cells.
In a detailed cytogenetic study of hybrids between a
murine melanoma and diploid fibroblasts or lymphocytes, it
was concluded that tumour suppression was seen only when
a hybrid retained one or both copies of the normal mouse
chromosome 4 (Jonasson et al., 1977). Copies of normal
chromosome 4 were also implicated in suppression of malig-
nancy of other types of tumour, and evidence was presented
that the ratio between numbers of normal and tumour-
derived chromosomes 4 was important in whether suppres-
sion was observed (Evans et al., 1982). The capacity for
suppression was localised to a specific region of this chromo-
some (Jonasson et al., 1977), restated to be bands A4-C3
(Harris, 1990). This contains a region of homology to human
chromosome 1, arm lp, chromosome 1 being associated with
suppression of malignancy of a hamster cell line (Stoler &
Bouck, 1985; Harris, 1990). There is also a small region
syntenic with human chromosome 6q (Ceci et al., 1989).
Human chromosome 6 has been directly shown, by microcell-
mediated chromosome transfer, to suppress malignancy of
two human melanoma lines in nude mice (Trent et al., 1990).
Human chromosome arms lp and 6q are those most com-
monly subject to deletions and translocations in melanomas
(Trent et al., 1989). One group has mapped a familial suscep-
tibility to cutaneous melanoma to human chromosome lp36
(Bale et al., 1989), although other groups have reported
conflicting data. All these findings suggest the loss of specific
normal genes in melanoma.
Here the genetic analysis was extended to cellular proper-
ties observed in vitro. It is concluded that, here too, proper-
ties of the normal pigment cells tend to be dominant over
those of melanoma cells, the most reliable being pigmenta-
tion and a positive growth response to TPA. These findings
are of considerable practical value, providing two relatively
rapid assays for the normal cellular gene or genes responsi-
ble. These assays will permit attempts at chromosome-medi-
ated or DNA-mediated transfer of these biological properties
from normal cells to melanoma cells. Any sequence capable
of conferring one or both properties would be most interest-
ing, not only as a candidate melanoma suppressor gene.
We are greatly indebted to Dr Ian Hart of the Imperial Cancer
Research Fund, London for supplying the B16-F1O and B16-FIORR
cell lines, and for carrying out the tumorigenicity tests; also to Drs
Ian Jackson and Robin Allshire (MRC Human Genetics Unit, Edin-
burgh) for the pUC-Y3 plasmid. This work was supported by the
Cancer Research Campaign.
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